ARCHIVES

NCI declined to pay for economic, quality of life analysis in Avastin, Erbitux study.

This article is from The Cancer Letter archive.

Vol. 31 No. 22 | June 3, 2005

Download PDF Visit The Full Archive

Related Articles

Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program

October 31, 2014

NCI CTEP Approved Trials For the Month of January

January 31, 2014

Congress Renews National Cancer Act, Including Most Key Amendments Sought By NCI And Allied

October 28, 1988

Bush To Propose Increase for Cancer Screening, FDA Generics Reviews

January 31, 2003

FDA Encourages Study Of Gender Differences

August 6, 1993

Herberman Outlines NSABP restructuring In Plan To NCI

May 6, 1994